Sortino ratio is not yet available for CYTO.V. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar stocks
The table compares Cytophage Technologies Ltd's Sortino Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how CYTO.V's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 6, 2026.
| Symbol | Name | 1Y Sortino Ratio | 5Y Sortino Ratio | 10Y Sortino Ratio | All Time Sortino Ratio |
|---|---|---|---|---|---|
| RVX.TO | Resverlogix Corp. | 2.26 | |||
| APLI.TO | Appili Therapeutics Inc. | 2.19 | |||
| HBP.TO | Helix BioPharma Corp. | 1.71 | |||
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | 1.69 | |||
| FRX.TO | Fennec Pharmaceuticals Inc. | 0.82 | |||
| APS.TO | Aptose Biosciences Inc. | 0.60 | |||
| MIR.V | MedMira Inc | 0.13 | |||
| MBX.TO | Microbix Biosystems Inc. | 0.00 | |||
| CSCI.TO | COSCIENS Biopharma Inc | -0.21 | |||
| MDNA.TO | Medicenna Therapeutics Corp. | -0.65 | |||
| CYTO.V | Cytophage Technologies Ltd | — |
Historical Sortino Ratio
The chart shows CYTO.V's rolling Sortino ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to downside risk, while declining trends may signal deteriorating risk-adjusted performance or increased volatility during market stress. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.
Identify market cycles by observing when CYTO.V consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.
Loading charts...
IHow does CYTO.V fit in your portfolio?
Add your other holdings to see your portfolio's Sortino Ratio and find out.
Analyze Your Portfolio